Scientists Discover Possible Treatment For Alzheimer’s Disease In Asthma Drug – Inventorspot

Scientists Discover Possible Treatment For Alzheimer's Disease In Asthma Drug
Inventorspot
by T Goodman Researchers at Temple University's School of Medicine have reported the results of their experiments using an asthma drug, Zileuton, in the treatment of Alzheimer's disease in mouse models. Their discoveries may lead to a major
Asthma drug could help fight Alzheimer's diseaseSify

all 9 news articles »

View full post on asthma – Google News

Possible Alternative Therapy for Adults with Poorly Controlled Asthma – news Stories


TopNews Arab Emirates

Possible Alternative Therapy for Adults with Poorly Controlled Asthma
news Stories
Tiotropium bromide, used for the treatment of chronic obstructive pulmonary disease (COPD) has been found to be successful in treating adults whose asthma
COPD Drug Spiriva May Also Benefit Those with AsthmaeMaxHealth
Now, alternate therapy for adults with poorly controlled asthmaSify
Study may give alternative to asthma sufferersDenver Post
FiercePharma –allvoices –Boston Herald
all 337 news articles »

View full post on asthma – Google News

Health Alerts: amphetamine abuse, possible link between acetaminophen, asthma – Dallas Morning News

Health Alerts: amphetamine abuse, possible link between acetaminophen, asthma
Dallas Morning News
Young teenagers who use acetaminophen even once a month develop asthma symptoms more than twice as often as those who never take it, a large international
Teen Tylenol Use May Lead To Asthma ProblemsCalorieLab Calorie Counter News
Tylenol Strikes Again Associated to Children Wheezing and Coughingallvoices

all 3 news articles »

View full post on asthma – Google News

After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis

Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less frequent treatments. Early results also suggest that patients with disease relapses — typically recurrences of fever, fatigue, kidney damage, or bleeding in the lungs — respond better to the new regimen.

View full post on National Institutes of Health (NIH) News Releases